Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04879368
Title RegoNivo vs Standard of Care Chemotherapy in AGOC (INTEGRATEIIb)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Australasian Gastro-Intestinal Trials Group
Indications

gastroesophageal junction adenocarcinoma

stomach carcinoma

gastroesophageal adenocarcinoma

gastric adenocarcinoma

Therapies

Docetaxel

Paclitaxel

Trifluridine-tipiracil hydrochloride

Nivolumab + Regorafenib

Irinotecan

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.